Comparative study of Ashwagandha for its effect on quality of life in patients during post-COVID19 period
Not Applicable
Completed
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2021/08/035755
- Lead Sponsor
- D Y Patil Medical College Hospital and Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 52
Inclusion Criteria
1. Subjects of either gender, aged 18 to 50 years
2. All adult patients aged >=18 years who present to the site for follow-up OPD
3. Laboratory-confirmed COVID-19 infection with SARS-CoV-2
4. Patients who agree to follow-up for up to three months.
5. Subjects able to understand and complete the study questionnaires
6. Subjects who sign the informed written consent
Exclusion Criteria
1. Patients aged below 18 years will be excluded.
2. Unwilling or unable to provide written informed consent,
3. Pregnant or breast-feeding women or women with positive urinary pregnancy test at screening.
4. Those who cannot be relied upon to comply with the test procedures or are unwilling to give
informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in the health summary scores from Short Form SF-36 Quality of life (SF-36 QoL)questionnaire at the end of 12 weeksTimepoint: screening, week 4, week 8 and week 12
- Secondary Outcome Measures
Name Time Method Change in scores for HAM-A at the end of 12 weeksTimepoint: screening, week 4, week 8 and week 12;Change in scores for HAM-D at the end of 12 weeksTimepoint: screening, week 4, week 8 and week 12;Changes in Cardio-Pulmonary Exercise Testing (CPET) results at the end of 12 weeksTimepoint: screening and week 12